Azintuxizumab, CAS 1826819-57-1

Product Description: Azintuxizumab is a monoclonal, targeting to B-cell maturation antigen (BCMA) and SLAMF7/CRACC/CD319, IgG1 bispecific antibody. Azintuxizumab has the potential for the research of relapsed/refractory multiple myeloma (RRMM)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]D'Souza A, et al. A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma. J Clin Oncol. 2022 Nov 1;40(31):3576-3586.

CAS Number: 1826819-57-1

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: ADC Antibody

• SKU: MEXHY-P99453-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99453-1
• Green Labware: No
• Package Unit: 1mg
• Quantity Unit: STK